Quantinno Capital Management LP Purchases 68,591 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Quantinno Capital Management LP grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 58.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 185,399 shares of the medical instruments supplier's stock after buying an additional 68,591 shares during the period. Quantinno Capital Management LP owned 0.09% of DENTSPLY SIRONA worth $3,519,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. increased its position in DENTSPLY SIRONA by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock valued at $383,078,000 after purchasing an additional 65,478 shares during the period. First Eagle Investment Management LLC boosted its stake in shares of DENTSPLY SIRONA by 2.5% in the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock valued at $275,218,000 after purchasing an additional 348,532 shares during the last quarter. Nuance Investments LLC increased its position in shares of DENTSPLY SIRONA by 25.0% during the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after buying an additional 2,708,097 shares during the period. Price T Rowe Associates Inc. MD increased its position in shares of DENTSPLY SIRONA by 18.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock worth $238,186,000 after buying an additional 1,975,404 shares during the period. Finally, Fuller & Thaler Asset Management Inc. raised its stake in DENTSPLY SIRONA by 2.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier's stock worth $219,018,000 after buying an additional 314,343 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on XRAY shares. Barrington Research increased their price target on DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an "outperform" rating in a report on Monday, May 12th. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Wall Street Zen upgraded DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Piper Sandler cut their price target on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a report on Wednesday, April 30th. Finally, UBS Group lowered their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research note on Friday, May 9th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $20.36.

DENTSPLY SIRONA Stock Up 0.1%

Shares of XRAY traded up $0.02 during trading hours on Thursday, reaching $15.85. The stock had a trading volume of 1,901,946 shares, compared to its average volume of 2,964,891. The firm has a 50-day simple moving average of $14.47 and a 200 day simple moving average of $17.24. DENTSPLY SIRONA Inc. has a 12 month low of $12.16 and a 12 month high of $28.44. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company has a market capitalization of $3.16 billion, a price-to-earnings ratio of -7.66, a P/E/G ratio of 1.80 and a beta of 0.92.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. The firm had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business's quarterly revenue was down 7.8% compared to the same quarter last year. During the same period last year, the firm earned $0.42 earnings per share. Equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were issued a $0.16 dividend. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.04%. DENTSPLY SIRONA's dividend payout ratio is presently -14.10%.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier acquired 15,142 shares of the company's stock in a transaction on Monday, March 3rd. The shares were acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.52% of the stock is owned by insiders.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.